InvestorsHub Logo
Followers 4
Posts 201
Boards Moderated 0
Alias Born 06/21/2020

Re: None

Monday, 10/26/2020 11:44:46 PM

Monday, October 26, 2020 11:44:46 PM

Post# of 233114

In early 2002, Dr. Rahman joined Centocor/Johnson & Johnson and was involved in the development of Infliximab, golimumab, ustekinumab and several small molecules as the Rheumatology Clinical Team Leader. “
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News